Your browser doesn't support javascript.
loading
Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence?
Fontanelli, Lorenzo; Vadi, Gabriele; Schirinzi, Erika; Di Rauso, Giulia; Bellini, Gabriele; Ricci, Giulia; Siciliano, Gabriele.
Affiliation
  • Fontanelli L; Health Science Interdisciplinary Centre, Sant'Anna School of Advanced Studies, Pisa, and Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. lorenzo.fontanelli@santannapisa.it.
  • Vadi G; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Schirinzi E; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Di Rauso G; Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Italy.
  • Bellini G; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Ricci G; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Siciliano G; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Clin Exp Rheumatol ; 42(2): 462-463, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38372729
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myositis, Inclusion Body / Myositis Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myositis, Inclusion Body / Myositis Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2024 Document type: Article Affiliation country: Italy Country of publication: Italy